Javaneh Khosravi Babadi - Pharmaceutical Sciences Research Center, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran-Iran (IAUPS)
Nooshin Barikrow - Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences & Technology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran - Iran (IAUPS) corresponding
Saeed Aminzadeh - Bioprocess Engineering Research Group, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology

Mesenchymal stem cells have variety of sources such as bone marrow, amniotic membrane and fluid. MSC have immunomodulatory properties. With these kind of cells, we can treatment many of diseases such as neurological diseases. Amniotic stem cells, in the transplantation have not any immunological or tumorigenic reactions and lacks any blood vessels and nerve fibers and this is a reasons that they are useful for treatment. In this study, we isolated mesenchymal stem cells from amniotic membrane, then used flow cytometery for study of surface markers. These cells Differentiate to osteoblasts and adipocytes. Finally, differentiate to nerve cell with bFGF and EGF as differentiate medium. After extracting RNA and synthesis CDNA we studied the expression of PAX2 and NURR1 genes with real time PCR. Then used Immunofluorescence and in this way studying the presence of β-tubulin III and MAPII protein. In conclusion, MCS differentiated to the each two type of osteoblasts and adipocytes. Studying MCS after treatment showed that these cells morphologically differentiate to nerve cell and the level of expression of mRNA of PAX2 and NURR1 was higher than the cells without differentiation treatment. Protect of Neurons is important in neurological diseases and Expression of mRNA such as PAX2, Nurr1, β-tubulin III and MAPII play an effective role on neural differentiation

Mesenchymal stem cell, Differentiate, Nerve cell, Amniotic membrane